Contribution of the MEOPA in the Physiotherapy Care of Painful Articular Steepness Among Elderly

Centre Hospitalier Universitaire de Nice

Status and phase

Unknown

Phase 4

Conditions

Pain Management and Care

Treatments

Drug: MEOPA

Study type

Interventional

Funder types

Other

Identifiers

NCT02230007

2013-000065-37

12AOI02 (Other Identifier)

Details and patient eligibility

About

The MEOPA is used to obtain an analgesia of the short-term painful acts. To the population of elderly patients, the therapeutic resources to control the passing pain require in their manipulation a certain caution and are not divested of side effects badly tolerated at this age. An alternative in the opioid presents all its interest. The MEOPA is here an alternative of choice in the care of these pains, in particular in case of pre-existent cognitive achievement, of polypathologies or of polymédication.

The gas MEOPA administered to the mask could thus be an effective additive in the physiotherapy treatment of the elderly person.

The main objective is to Assess the efficacy , in terms of recovery of the hip and knee joint articular amplitude, of 3 sessions of reeducation using MEOPA versus standard reeducation within a population of elderly patients presenting a pain during the physiotherapy treatment.

Enrollment

64 estimated patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Male or female aged 65 years old or more
Patients having a prescription for physiotherapy
Absence of contraindication to MEOPA
Patients whose initial assessment show a passive articular deficit of at least a joint of hip or the knee and whose painful assessment is ≥ 5 or ≥ 2 during mobilisation on the validated scale Algoplus
Patients whose reeducation project established by the physiotherapist
Patients having agreed to participate in the study and having signed the consent
Subjects affiliated to the social security system

Exclusion criteria

Patient requiring a ventilation in pure oxygen
Patient with a consciousness deterioration preventing his cooperation
Care under MEOPA during the period of the protocol and during the month which precedes
Increase of the dosage of morphine of less than 48 hours Patient under guardianship